Corporate and Commercial Legal Updates in India

  Acquiring a pharmaceutical business involves far more than reviewing its revenue, products and financial statements. Pharmaceutical companies operate within a highly regulated environment, where licences, product approvals, manufacturing standards, intellectual property and regulatory history can directly affect the value of the business. A buyer may acquire a company with an attractive product portfolio but later discover unresolved regulatory issues, weak quality controls or restrictions on important intellectual property. Such issues can affect operations and create significant costs after completion. Pharmaceutical M&A due diligence therefore needs to examine the legal, regulatory, commercial and operational position of the target. The objective is to understand what is being acquired, which risks may continue after completion and whether the business can maintain its operations under new ownership. Review the Corporate Structure The first step is understanding how the ta...

  Healthcare acquisitions involve more than assessing revenue, assets and growth prospects. A buyer also needs to understand the regulatory responsibilities attached to the target business. Hospitals, pharmaceutical companies, diagnostic centres, medical device businesses and digital health companies operate within detailed regulatory frameworks. Their licences, approvals, professional obligations, product standards and data practices can all affect the value and continuity of the business. A regulatory issue may not always appear as a conventional financial liability. However, it can create significant costs after an acquisition. A missing approval, unresolved investigation or non compliant product can affect operations, reputation and future investment. This is why regulatory liabilities should form an important part of healthcare M&A due diligence. What Are Regulatory Liabilities? Regulatory liabilities are obligations, risks or potential consequences arising from a company'...

  Mergers and acquisitions require careful due diligence in almost every industry. Buyers generally examine a target's financial position, contracts, assets, liabilities, employees, litigation and regulatory compliance before completing a transaction. Healthcare M&A requires a wider examination. A healthcare business may operate hospitals, clinics, laboratories, pharmacies, diagnostic centres or digital health platforms. Its operations can involve patients, medical professionals, licences, clinical records, medicines, medical devices and highly sensitive personal information. This creates risks which may not arise in the same form in a conventional commercial transaction. The Indian healthcare sector also has a complex regulatory environment. The India Code database lists legislation covering areas such as clinical establishments, medical professionals, pharmaceuticals, mental healthcare and allied healthcare professions. As a result, healthcare M&A due diligence needs to e...